Explore our ACCC 2020 Impact Report, the Oncology Issues, Vol.36, N.4, and our video podcast, CANCER BUZZ TV.




The Biomarker Testing Implementation Roadmap for Advanced Non-Small Cell Lung Cancer (NSCLC) is an innovative learning tool that can help multidisciplinary cancer care teams obtain the knowledge they need to implement, expand, and sustain biomarker testing for patients with advanced NSCLC. The Roadmap will give users information about how to lay the groundwork for biomarker testing, train and prepare their care team to offer testing, implement the testing, and evaluate ongoing progress. “Expert Insights” from the Advisory Committee that informed the Roadmap give teams a deeper understanding of how biomarker testing fits into their cancer program. Accompanying resources provide more information and are available in the Resource Library.

Sharing Article:

Our Partners


Our Supporter

This project is sponsored by Amgen.